Phibro Animal Health Corp
PAHC40.060USD
+0.190+0.48%
종가 01/15, 16:00（ET）시세는 15분 지연됩니다
1.62B시가총액
23.94P/E TTM
자세한 내용은 Phibro Animal Health Corp 회사
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Phibro Animal Health Corp 정보
종목 코드 PAHC
회사 이름Phibro Animal Health Corp
상장일Apr 11, 2014
CEOBendheim (Jack C)
직원 수2475
유형Ordinary Share
회계 연도 종료Apr 11
주소Glenpointe Centre East, 3Rd Floor
도시TEANECK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호07666
전화12013297300
웹사이트https://www.pahc.com/
종목 코드 PAHC
상장일Apr 11, 2014
CEOBendheim (Jack C)
Phibro Animal Health Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Jack C. Bendheim
Mr. Jack C. Bendheim
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Mary Lou Malanoski
Ms. Mary Lou Malanoski
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
31.24K
+1242.00%
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
30.00K
-5184.00%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
30.00K
-4845.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
+3964.00%
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
+3268.00%
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
+1793.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
지역별USD
이름
수익
비율
United States
202.35M
55.61%
Latin America and Canada
87.23M
23.97%
Europe & Middle East & Africa
44.94M
12.35%
Asia Pacific
29.38M
8.07%
사업별
지역별
사업별USD
이름
수익
비율
MFAs and Other
195.20M
53.64%
Nutritional specialties
48.15M
13.23%
Vaccines
40.11M
11.02%
주식 보유 통계
마지막 업데이트: Tue, Nov 18
마지막 업데이트: Tue, Nov 18
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
기타
67.35%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
14.28%
The Vanguard Group, Inc.
7.44%
State Street Investment Management (US)
4.37%
Acadian Asset Management LLC
3.84%
Renaissance Technologies LLC
2.72%
기타
67.35%
주주 유형
주주
비율
Investment Advisor
55.65%
Investment Advisor/Hedge Fund
29.60%
Hedge Fund
8.81%
Research Firm
3.30%
Pension Fund
1.72%
Individual Investor
0.52%
Bank and Trust
0.46%
Corporation
0.19%
Sovereign Wealth Fund
0.05%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
421
20.39M
99.73%
-3.12M
2025Q3
390
21.83M
106.75%
-2.29M
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
2.92M
14.28%
-23.05K
-0.78%
Sep 30, 2025
The Vanguard Group, Inc.
1.52M
7.44%
-22.54K
-1.46%
Sep 30, 2025
State Street Investment Management (US)
894.04K
4.37%
-15.29K
-1.68%
Sep 30, 2025
Acadian Asset Management LLC
785.82K
3.84%
+61.38K
+8.47%
Sep 30, 2025
Renaissance Technologies LLC
555.20K
2.72%
-55.60K
-9.10%
Sep 30, 2025
Geode Capital Management, L.L.C.
547.16K
2.68%
-7.77K
-1.40%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
485.51K
2.37%
-71.73K
-12.87%
Sep 30, 2025
Nuveen LLC
478.02K
2.34%
+19.45K
+4.24%
Sep 30, 2025
Fidelity Management & Research Company LLC
413.62K
2.02%
+354.02K
+594.03%
Sep 30, 2025
Castleknight Management LP
399.78K
1.96%
-131.56K
-24.76%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
AAM Sawgrass US Small Cap Quality Growth ETF
2.49%
State Street SPDR S&P Pharmaceuticals ETF
1.19%
Innovator IBD 50 Fund ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
1.06%
Inspire Fidelis Multi Factor ETF
1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.02%
Lattice Hartford Multifactor Small Cap ETF
0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco NASDAQ Future Gen 200 ETF
0.61%
Invesco S&P SmallCap Health Care ETF
0.52%
더 보기
AAM Sawgrass US Small Cap Quality Growth ETF
비율2.49%
State Street SPDR S&P Pharmaceuticals ETF
비율1.19%
Innovator IBD 50 Fund ETF
비율1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
비율1.06%
Inspire Fidelis Multi Factor ETF
비율1.06%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
비율1.02%
Lattice Hartford Multifactor Small Cap ETF
비율0.92%
Invesco Dorsey Wright Healthcare Momentum ETF
비율0.76%
Invesco NASDAQ Future Gen 200 ETF
비율0.61%
Invesco S&P SmallCap Health Care ETF
비율0.52%
주식 배당금
지난 5년 동안 총
97.20M
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Nov 04, 2025
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 17, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 17, 2025
Nov 26, 2025
Jul 29, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 24, 2025 going ex on Sep 03, 2025
Sep 03, 2025
Sep 24, 2025
Sep 03, 2025
May 06, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 25, 2025 going ex on Jun 04, 2025
Jun 04, 2025
Jun 25, 2025
Jun 04, 2025
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
더 보기
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
자주 묻는 질문
Phibro Animal Health Corp의 상위 5대 주주는 누구인가요?
Phibro Animal Health Corp의 상위 5대 주주는 다음과 같습니다:
BlackRock Institutional Trust Company, N.A.는 2.92M주의 주식을 보유하고 있으며, 전체 주식의 14.28%를 차지합니다.
The Vanguard Group, Inc.는 1.52M주의 주식을 보유하고 있으며, 전체 주식의 7.44%를 차지합니다.
State Street Investment Management (US)는 894.04K주의 주식을 보유하고 있으며, 전체 주식의 4.37%를 차지합니다.
Acadian Asset Management LLC는 785.82K주의 주식을 보유하고 있으며, 전체 주식의 3.84%를 차지합니다.
Renaissance Technologies LLC는 555.20K주의 주식을 보유하고 있으며, 전체 주식의 2.72%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 2.92M주의 주식을 보유하고 있으며, 전체 주식의 14.28%를 차지합니다.
The Vanguard Group, Inc.는 1.52M주의 주식을 보유하고 있으며, 전체 주식의 7.44%를 차지합니다.
State Street Investment Management (US)는 894.04K주의 주식을 보유하고 있으며, 전체 주식의 4.37%를 차지합니다.
Acadian Asset Management LLC는 785.82K주의 주식을 보유하고 있으며, 전체 주식의 3.84%를 차지합니다.
Renaissance Technologies LLC는 555.20K주의 주식을 보유하고 있으며, 전체 주식의 2.72%를 차지합니다.
Phibro Animal Health Corp의 상위 3대 주주 유형은 무엇인가요?
Phibro Animal Health Corp의 주요 주주 유형 상위 3가지는
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)입니다.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
State Street Investment Management (US)입니다.
Phibro Animal Health Corp(PAHC)의 주식을 보유한 기관은 몇 개입니까?
2025Q4 기준으로, Phibro Animal Health Corp의 주식을 보유한 기관은 총 421곳이며, 이들이 보유한 주식의 총 가치는 약 20.39M로 전체 발행 주식의 99.73%를 차지합니다. 이는 2025Q3 대비 -7.02% 증가한 수치입니다.
Phibro Animal Health Corp의 최대 수익원은 무엇인가요?
FY2026Q1 기준, Phibro Animal Health Corp의 MFAs and Other 부문이 가장 높은 매출을 기록했으며, 금액은 195.20M로 전체 매출의 53.64%를 차지했습니다.
